1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum

C46H42N6O2Pt2-6 — CID 165155014

IUPAC1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum
SMILESCN1[CH-]N(c2[c-]c(Oc3[c-]c(-c4[c-]c(Oc5[c-]c(N6[CH-]N(C)c7ccccc76)cc(C(C)(C)C)c5)ccn4)ncc3)cc(C(C)(C)C)c2)c2ccccc21.[Pt].[Pt]
InChIInChI=1S/C46H42N6O2.2Pt/c1-45(2,3)31-21-33(51-29-49(7)41-13-9-11-15-43(41)51)25-37(23-31)53-35-17-19-47-39(27-35)40-28-36(18-20-48-40)54-38-24-32(46(4,5)6)22-34(26-38)52-30-50(8)42-14-10-12-16-44(42)52;;/h9-24,29-30H,1-8H3;;/q-6;;
InChIKeyXRBWDXRDWOLSQI-UHFFFAOYSA-N
MW1101.04 g/mol
LogP10.93
Rot. Bonds7

About 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum

1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum (PubChem CID 165155014) has the molecular formula C46H42N6O2Pt2-6 and a molecular weight of 1101.04 g/mol. Its IUPAC name is 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum.

Molecular Properties

Compound Name1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum
PubChem CID165155014
Molecular FormulaC46H42N6O2Pt2-6
Molecular Weight1101.04 g/mol
Exact Mass1100.27
IUPAC Name1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum
SMILESCN1[CH-]N(c2[c-]c(Oc3[c-]c(-c4[c-]c(Oc5[c-]c(N6[CH-]N(C)c7ccccc76)cc(C(C)(C)C)c5)ccn4)ncc3)cc(C(C)(C)C)c2)c2ccccc21.[Pt].[Pt]
InChIInChI=1S/C46H42N6O2.2Pt/c1-45(2,3)31-21-33(51-29-49(7)41-13-9-11-15-43(41)51)25-37(23-31)53-35-17-19-47-39(27-35)40-28-36(18-20-48-40)54-38-24-32(46(4,5)6)22-34(26-38)52-30-50(8)42-14-10-12-16-44(42)52;;/h9-24,29-30H,1-8H3;;/q-6;;
InChIKeyXRBWDXRDWOLSQI-UHFFFAOYSA-N
XLogP10.93
TPSA57.20 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms56
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001101.04
LogP ≤ 510.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum?
The IUPAC name of 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum (CID 165155014) is 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum.
What is the SMILES notation for 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum?
The canonical SMILES for 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum is CN1[CH-]N(c2[c-]c(Oc3[c-]c(-c4[c-]c(Oc5[c-]c(N6[CH-]N(C)c7ccccc76)cc(C(C)(C)C)c5)ccn4)ncc3)cc(C(C)(C)C)c2)c2ccccc21.[Pt].[Pt].
What is the InChIKey of 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum?
The InChIKey is XRBWDXRDWOLSQI-UHFFFAOYSA-N. The full InChI is InChI=1S/C46H42N6O2.2Pt/c1-45(2,3)31-21-33(51-29-49(7)41-13-9-11-15-43(41)51)25-37(23-31)53-35-17-19-47-39(27-35)40-28-36(18-20-48-40)54-38-24-32(46(4,5)6)22-34(26-38)52-30-50(8)42-14-10-12-16-44(42)52;;/h9-24,29-30H,1-8H3;;/q-6;;.
What are the key properties of 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum?
1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum has a molecular weight of 1101.04 g/mol, XLogP of 10.93, 7 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-tert-butyl-5-[[2-[4-[3-tert-butyl-5-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-6-id-1-yl]oxy-3H-pyridin-3-id-2-yl]-3H-pyridin-3-id-4-yl]oxy]benzene-6-id-1-yl]-3-methyl-2H-benzimidazol-2-ide;platinum is sourced from PubChem (CID 165155014), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).